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Abstract. The surface expression of /3 2-integrins was investigated in
leukocytes from patients undergoing ischemia induced by tourniquet
application for elective hand surgery. Blood samples were obtained before
initiation, at the end of ischemia, and after 15 minutes of reperfusion
from ischemic and contralateral arms of five patients. Comparable
expression of CD18, CD11a, CD11b, and CD11c could be detected by
immunofluorescence in leukocytes from samples drawn from either arm
before tourniquet application. In contrast, a significant increase in the
expression of CD18 was detectable in monocytes, granulocytes, and
lymphocytes from the ischemic arm compared with that in the nonisch-
emic contralateral control, at the end of the ischemia time (80 ± 16
minutes). A significantly increased expression of CDl1b, but not CD11a
or CD11c, determinants was also observed in granulocytes and mono-
cytes. Concomitantly, a significant reduction in the percentages of gran-
ulocytes in samples from ischemic areas was detectable. After 15 minutes
of reperfusion, differences in the expression of these adhesion molecules
were no longer significant. The expression of the genes encoding inter-
leukins IL-la, IL-1, and IL-6 and tumor necrosis factor alpha (TNFa)
proinflammatory cytokines was also studied by reverse polymerase chain
reaction (rPCR) in peripheral blood mononuclear cells (PBMCs) ob-
tained from the same samples in three patients. IL-1/3 or IL-6 gene
expression was never observed. Expression of IL-la and TNFa genes, as
detected in two patients, was not related with induction of ischemia.
However, in these patients expression of one or both these genes was
observed in samples derived from the ischemic but not the control arm
after 15 minutes of reperfusion. These data document that overexpression
of adhesion molecules and sequestration of leukocytes take place follow-
ing short ischemia times, as routinely applied clinically for minor surgical
procedures.
lschemia/reperfusion injury represents a potential complication of
vascular injury, trauma, and transplantation surgery. Activation of
leukocytes, endothelium, or both leading to increased cell adhe-
sion and extravasation can result in damage of the vessel walls and
surrounding tissues, particularly during the reperfusion phase.
Furthermore, cytokines and other mediators can be produced,
possibly responsible for distant effects targeting the liver and the
pulmonary capillary area [1, 2].
Experimental models have addressed in detail the molecular
bases of ischemia reperfusion damage. Leukocyte infiltration, as
Correspondence to: P.M. Sutter, M.D., Surgical Research Laboratory,
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detectable in postischemic tissues, appears to largely mediate
injury induction. Indeed, leukocyte depletion has been shown to
decrease the severity of reperfusion damage, and monoclonal
antibodies (mAbs) specific for CD18 protect tissues from post-
ischemic injury [3-8].
Clinically, tourniquet-induced ischemia is routinely applied
during limb surgery to ensure a relatively bloodless operative
field. If prolonged in time, it may lead to skeletal muscle damage
and impaired postoperative function [9-11]. However, clinical
data concerning the activation of adhesion molecules in leuko-
cytes during ischemia and reperfusion are sparse to date.
In this work we took advantage of tourniquet application in
elective hand surgery to investigate the surface expression of
132 -integrins in different leukocyte populations under ischemic and
postischemic conditions. Concomitantly, the induction of proin-
flammatory cytokines' gene expression was assayed by the reverse
polymerase chain reaction (rPCR).
We report here that a significant increase in the expression of
Mac-1 (CD1Ib/CD18) (3 2- integrin is detectable in granulocytes
and monocytes from arms undergoing relatively short (60-101
minutes) ischemia times. Under these conditions, proinflamma-
tory cytokines do not appear to play a role the induction of these
events.
Patients and Methods
Experimental Design
Five patients undergoing elective hand surgery (Table 1) in the
absence of systemic diseases were studied. All patients except one
were anesthetized with regional brachial block anesthesia. No
Esmarch bandage exsanguination was applied. Heparinized ve-
nous blood samples were obtained from both arms before initia-
tion of surgery but after induction of anesthesia in the limb
undergoing surgery. Subsequently, a tourniquet was applied on
the upper arm at a pressure of 300 mmHg. Duration of ischemia
ranged between 60 and 101 minutes (80 ± 16 minutes). At the end
of surgery and immediately before releasing the tourniquet, a
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Table 1. Patient characteristics
Patient
Age
(years) Sex Surgery Anesthesia
Duration of
ischemia (min)
1 22 M Internal fixation of scaphoid fracture Regional 90
2 19 M Flexor tenolysis (little finger) Regional 60
3 36 F Ulnar head resection Regional 81
4 43 M Scapholunate ligament reconstruction Regional 101
5 49 F Excision of a hemangioma at the back of the hand General 70
Table 2. Pairs of primers used in this study
Gene Sequence Size"
/3-Actin Sense: TGACGGGGTCACCCACACTGTGCCCATCTA 661
Antisense: CTAGAAGCATTGCGGTGGACGATGGAGGG
IL-1a Sense: ATGGCCAAAGTTCCAGACATGTTTG 808
Antisense: GGTTTTCCAGTATCTGAAAGTCAGT
IL-1/3 Sense: CTTCATCTTTTGAAGAAGAACCTATCTTCTT 331
Antisense: AATI'I"ITGGGATCTACACTCTCCAGCTGTA
IL-6 Sense: ATGAACTCCTTCTCCACAAGCGC 628
Antisense: GAAGAGCCCTCAGGCTGGACTG
TNFa Sense: ATGAGCACTGAAAGCATGATCCGG 694
Antisense: GCAATGATCCCAAAGTAGACCTGCCC
"Expected size of the amplified fragment expressed as number of basepairs
second blood sample was obtained from both arms. A third
sample was obtained from both limbs 15 minutes after the
termination of ischemia. In some experiments another blood
specimen was obtained 1 minute after release of the tourniquet.
Phenotypic Studies
Phenotypic studies were performed on whole blood to avoid
separation procedures likely to affect the expression of adhesion
molecules [12]. Briefly, 50 µl of heparinized venous blood were
incubated in the presence of fluorochrome-labeled mAbs recog-
nizing CD14, CD45, CD11b (Becton-Dickinson, San Jose, CA,
USA). The mAbs directed against CD11a, CD11c, CD18, and
CD54 (ICAM-1) were obtained from Serotec (Oxford, UK).
Erythrocytes were lysed (FACS lysis buffer, Becton-Dickinson)
after 15 minutes of incubation at room temperature. Following
two washes, cells were resuspended in phosphate-buffered saline
(PBS) 0.2% paraformaldehyde, and specific fluorescence was
quantitatively evaluated on a FACScan fluorocytometer equipped
with Lysis lI software (Becton-Dickinson). The instrument's set-
tings were adjusted by taking advantage of CaliBRITE beads and
AutoComp software (both from Becton-Dickinson). Student's
t-test for paired samples was used in the statistical analysis of data
throughout this study.
PCR Studies
Peripheral blood mononuclear cells were obtained from hepa-
rinized venous blood samples by centrifugation on density gradi-
ents (Lymphoprep; Nycomed, Oslo, Norway). Total cellular RNA
was extracted and reverse-transcribed as described previously
[13]. The cDNA thus obtained was assayed in 35-cycle PCR
reactions in the presence of pairs of primers specific for -actin
housekeeping gene as the positive control and interleukins IL-la,
IL-1/3, and IL-6 and tumor necrosis factor alpha (TNFa) genes
(Table 2). PCR products were then electrophoresed in the
presence of ethidium bromide on agarose gels that were subse-
quently photographed under ultraviolet (UV) transillumination.
The specificity of the amplified genes was validated by restriction
mapping [13].
Results
Effects of Ischemia on Leukocyte Populations
Absolute counts of leukocytes did not significantly differ in blood
samples drawn from the ischemic or the control arm at any of the
time points under investigation (data not shown). Percentages of
granulocytes, monocytes, and lymphocytes in blood samples were
evaluated by taking advantage of physical cytometric parameters
[forward scatter (FSC) and side scatter (SSC)] and phenotypic
characteristics. Monocytes are CD14/CD45 + cells, whereas lym-
phocytes are CD14/CD45 bright cells and granulocytes appear as
CD14/CD45 dim cells. No differences in the relative percentages
of granulocytes, monocytes, and lymphocytes were observed in
samples drawn from either limb before ischemia. In contrast, at
the end of ischemia, as reported in Figure 1, a significant decrease
of the granulocytes' percentages could be observed in samples
obtained from the ischemic arm (57.7 ± 9.7%) compared with
values simultaneously obtained from the nonischemic limb
(71.1 ± 9.5%). In parallel, increased lymphocytes' percentages
were detected in the same specimens (38.2 ± 9.1% versus 24.2 ±
8.6%). No significant modifications of the monocytes' percentages
were detectable under these conditions. After 15 minutes of
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Fig. 1. Differential percentages of leukocytes. Percentages of granulocytes,
monocytes, and lymphocytes in blood samples from ischemic and
nonischemic areas. Heparinized blood was obtained at the indicated
times from ischemic limbs (shaded columns) and control limbs (open
columns). The percentages of granulocytes (G), monocytes (M), and
lymphocytes (L) among the total leukocytes were evaluated by staining
with fluorochrome-labeled anti-CD14 and anti-CD45 mAbs. Data from
the five patients under investigation are reported as mean values ±
standard deviations. Asterisks indicate significant differences (p < 0.05).
For other details see Materials and Methods.
reperfusion, comparable percentages of granulocytes, monocytes,
or lymphocytes were observed in samples obtained from the two
limbs (Fig. 1).
CD18 Expression in Leukocytes from Ischemic Areas
Surface expression of CD18 was quantitatively evaluated in
granulocytes, monocytes, and lymphocytes from ischemic and
nonischemic arms before application of the tourniquet, at the end
of ischemia, and after 15 minutes of reperfusion. As shown in
Figure 2, CD18 expression in leukocyte populations was compa-
rable in samples obtained from the two arms before ischemia
(206.8 ± 72.2 versus 174.0 ± 42.8 for granulocytes, 387.4 ± 156.8
versus 349.2 ± 95.7 for monocytes, 239.4 ± 42.5 versus 243.8 ±
23.1 for lymphocytes). A significant increase of CD18 expression
concerning all leukocyte populations was detected in samples
derived from the ischemic arm at the end of ischemia compared
with those obtained from the contralateral limb (321.2 ± 50.2
versus 188.8 ± 37.5 for granulocytes, 653 ± 54.4 versus 426.0 ±
121.6 for monocytes, 299.0 ± 44.5 versus 228.2 ± 36.0 for
lymphocytes). After 15 minutes of reperfusion, regarding granu-
locytes and monocytes, apparent differences in the expression of
CD18 in samples obtained from the ischemic arm compared with
the untreated arm (331.4 ± 72.5 versus 234.8 ± 66.9 for granu-
locytes, 567.4 ± 157.4 versus 443.2 ± 120.8 for monocytes) were
no longer significant. Regarding lymphocytes, virtually identical
values were observed in cells from the two arms (222.2 ± 48.7
versus 220.0 ± 56.9).
Fig. 2. Surface expression of CD18 in leukocytes from ischemic and
nonischemic areas. Expression of CD18 was evaluated quantitatively, as
the mean fluorescence intensity, in granulocytes (G), monocytes (M), and
lymphocytes (L) from blood samples obtained at the indicated times from
ischemic arms (shaded columns) and nonischemic arms (open columns).
Data from the five patients, expressed in arbitrary units, are reported as
mean values ± standard deviations. Asterisks indicate significant differ-
ences (p < 0.05). For other details see Materials and Methods.
a-chains was also investigated. As shown in Figure 3, CD11b
expression before ischemia was comparable in leukocyte popula-
tions in samples from either arm. In contrast, CD11b expression
was significantly increased in granulocytes (499.8 ± 341.7 versus
213.0 ± 149.8) and monocytes (532.8 ± 358.6 versus 237.3
205.9) from the ischemic arm compared with cells derived from
the contralateral limb at the end of ischemia. At close resem-
blance to CD18, apparent differences detectable after 15 minutes
of reperfusion (474.4 ± 281.7 versus 284.6 ± 214.4 for granulo-
cytes and 531.8 ± 358.1 versus 345 ± 291.8 for monocytes) were
no longer significant. On the other hand, no modifications of
CD11b expression were observed on lymphocyte surfaces at any of
the times considered. Remarkably, no significant differences in
the expression of CD11a and CD11c were detectable in leukocyte
populations at any time (data not shown).
ICAM-1 /CD54 Expression in Leukocytes from Ischemic or
Nonischemic Areas
Because ICAM-1/CD54 represents a major ligand molecule for
CD11a and CD11b integrins, its expression was analyzed in
leukocytes from ischemic and nonischemic limbs. At a striking
difference with CD18, no significant variation in the surface
expression of ICAM-1/CD54 could be detected in granulocytes,
monocytes, or lymphocytes following ischemia compared to the
expression in cells from the nonischemic limb (data not shown).
Cytokine Gene Expression in Mononuclear Cells from Ischemic
or Nonischemic Areas
Effects of Ischemia on Expression of a-Chains of /32- Integrins
on Leukocyte Surfaces	 Expression of IL-la, IL-1J3, IL-6, and TNFa genes was investi-
gated by 35-cycle rPCR in RNA from peripheral blood mononu-
Because ischemia appeared to increase surface expression of clear cells (PBMCs) obtained simultaneously with the samples
CD18, the common 13-chain of (32-integrins, the expression of used for phenotypic studies. Three patients were studied. The
182
	 World J. Surg. Vol. 21, No. 2, February 1997
Fig. 3. Surface expression of CD11b in leukocytes from ischemic and
nonischemic areas. Expression of CD11b was evaluated quantitatively, as
the mean fluorescence intensity, in granulocytes (G), monocytes (M), and
lymphocytes (L) from blood samples obtained at the indicated times from
ischemic arms (shaded columns) and nonischemic arms (open columns).
Data from the five patients, expressed in arbitrary units, are reported as
means ± standard deviations. Asterisks indicate significant differences
(p < 0.05). For other details see Materials and Methods.
(3-actin housekeeping gene was expressed in all samples, testifying
to the integrity of the test system. IL-113 and IL-6 transcripts could
not be detected in any of the samples under investigation. In
patient 1, IL-la gene expression was barely detectable in preisch-
emia samples. On the other hand, this gene was found to be
relatively highly expressed in samples from both ischemic and
control arms at the end of ischemia and after 1 minute of
reperfusion as well as in PBMCs from the ischemic limb only after
15 minutes of reperfusion. In contrast, no expression could be
observed in the 15-minute reperfusion sample from the nonisch-
emic control arm (Fig. 4, Table 3). Regarding TNFa gene, in this
patient weak expression was observed in all samples, with the
exception of PBMCs obtained after 15 minutes of reperfusion
from the control arm. Interestingly, TNFa expression was also
detectable in PBMCs from patient 3 obtained from the ischemic
arm after 15 minutes of reperfusion (Table 3).
Discussion
The mechanisms underlying ischemia/reperfusion-associated in-jury have been thoroughly investigated in a number of experimen-
tal models [14, 15]. Emerging evidence concordantly attributes a
key role to leukocytes in the generation of postischemic damage.
Overexpression of adhesion molecules and production of proin-
flammatory cytokines would lead to leukocyte infiltration of
postischemic tissues, a key step in the induction of reperfusion
injury [16]. Furthermore, leukocyte—endothelial cell adhesion is
thought to create a microenvironment favoring the release of toxic
products, including reactive oxidant metabolites [17]. In this
context, evidence that administration of CD18-specific mAbs can
prevent generation of mucosal damage following intestinal isch-
emia [7-9] suggests a major relevance of these molecules in the
induction of ischemia/reperfusion-related injury.
Despite myriad experimental data, however, little information
is available on these events as detectable in clinical situations.
Significant neutropenia and reduction of the percentages of
granulocytes expressing CD11b/CD18 and CD11c/CD18 was ob-
Fig. 4. Cytokine gene expression in peripheral blood mononuclear cells
(PBMCs) from ischemic and nonischemic areas. Total cellular RNA was
extracted from Ficoll-purified PBMCs and reverse-transcribed. The
cDNA thus obtained was amplified by 35-cycle PCR in the presence of
primers specific for /3-actin (A), IL -la (B), and TNF-a (C). PCR products
were electrophoresed in the presence of ethidium bromide and photo-
graphed under UV transillumination. Samples were obtained before
initiation of ischemia (lanes 1 and 2), at the end of ischemia (lanes 3 and
4), after 1 minute of reperfusion (lanes 5 and 6), and after 15 minutes of
reperfusion (lanes 7 and 8). Lanes 1, 3, 5, and 7 contain samples from the
ischemic arm, whereas lanes 2, 4, 6, and 8 contain samples from the
contralateral arm. For other details see Materials and Methods.
served in patients affected by peripheral arterial occlusive disease
following physical exercise [18].
In this work we analyzed the expression of p2 integrins in a
group of patients undergoing elective hand surgery, implying
application of a tourniquet and an ischemia time ranging between
60 and 101 minutes. Differently from most experimental models,
however, we specifically addressed the expression of adhesion
molecules at the end of ischemia and after a short (15-minute)
reperfusion.
In keeping with observations in animal models, we found that
relatively short ischemia times, as required for technical reasons
during minor surgical procedures, induce overexpression of CD18
on the surface of granulocytes, monocytes, and lymphocytes. In
parallel, a concomitant, significant increase in the expression of
CD11b, but not CD11a or CD11c, is detectable on granulocytes
and monocytes. Local sequestration of granulocytes was also
observed, as witnessed by their decreased percentages in effluent
blood. Considering the relatively rapid kinetics of these phenom-
ena, translocation of adhesion molecules from intracellular gran-
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Table 3. Expression of proinflammatory cytokine genes in PBMCs from ischemic and nonischemic areas.
Time 0 End ischemia Reperfusion 1 min Reperfusion 15 minCytokine
gene I s C Is C Is	 C Is	 C
Patient 1
(3-Actin" +++ +++ +++ +++ +++	 +++ +++	 +++
IL-la + + ++ ++ ++	 ++ ++
IL-1(3 — —	 — —
IL-6 — — — — —	 — —	 —
TNFa + + + + +	 + +	 —
Patient 2
(3-Actin +++ +++ +++ +++ +++	 +++ +++	 +++
IL-la — — — — —	 — —	 —
IL-lp — — — — —	 — _	 —
IL-6 — — — — —	 — —	 —
TNFa — —	 — —	 —
Patient 3
(3-Actin +++ +++ +++ +++ +++	 +++ +++	 +++
IL-la — — — — —	 — —
IL-1(3 — — — — —	 — —	 —
IL-6 — — — — —	 — —	 —
TNFa — — — —	 — ++	 —
Total cellular RNA was extracted from PBMCs obtained from blood samples drawn at the indicated times from ischemic (Is) or contralateral (C)
arms and reverse-transcribed.
"cDNA was assayed during 35-cycle PCR in the presence of the appropriate pairs of primers (see Table 2). Amplification products were run on
agarose gels in the presence of ethidium bromide and photographed under UV transillumination.
—: no detectable PCR product; +—+ + +: intensity (in arbitrary units) of the fluorescence emitted by amplified genes under investigation following
electrophoresis in the presence of ethidium bromide (see also Fig. 4).
ules to the cell surfaces, as observed in experimental models [19],
is highly likely.
Granulocytes and monocytes obtained from the ischemic arm
after 15 minutes of reperfusion still display an apparently higher
expression of CD18 and CD11b than did their counterparts
sampled simultaneously from the nonischemic limb. These differ-
ences, however, are no longer significant. This could be related to
the "dilution" of the blood from the ischemic area into the
systemic circulation.
It has been suggested that cytokine production by leukocytes
trapped in ischemic areas might activate both leukocytes and
endothelial cells, resulting in the overexpression of adhesion
molecules and their ligands [20]. White blood cell sequestration
would ensue. Our data on cytokine gene expression in PBMCs do
not support this hypothesis. In fact, no IL-1f3 or IL-6 transcripts
could be amplified. As for IL-la and TNFa genes, in two of three
patients no expression was detectable in mononuclear cells from
the ischemic arm at the end of ischemia. Furthermore, expression
of these genes in patient 1 did not appear to be directly related to
the ischemia inasmuch as it was also observed in samples from the
contralateral, nonischemic arm. Clearly, we cannot exclude that
other relevant cytokines, possibly produced by other cell types,
might be involved.
It is worth noting, however, that in two of three patients we
observed a discrepancy in cytokine gene expression in PBMCs
from blood sampled from the two arms after 15 minutes of
reperfusion. Based on these data and taking into account the high
sensitivity of rPCR, it is tempting to speculate that activated cells,
expressing cytokine genes, could be sequestered in the ischemic
areas following adhesion to activated endothelial cells and slowly
released in the systemic blood flow.
Taken together, our data document that after routine minor
surgical procedures, usually devoid of significant postsurgery
complications, molecular events typically involved in the genera-
tion of postischemic damage are observed.
Resume
L'expression de surface des integrins (3 2
 des leucocytes a ete
analysec chez les patients operes de la main ayant une ischemie
induite par un garrot applique an niveau du bras. On a preleve du
sang aux deux bras, chez cinq patients, avant et 15 minutes apres
l'ischemie provoquee. Par immunofluorescence on a mis en
evidence 1'expression des integrins CD18, CD11a, CD11b et
CD11c. L'expression avant l'ischemie etait comparable dans les
deux bras. Par contre, on a retrouve a la fin de l'ischemie
provoquee (80 ± 16 minutes) une augmentation significative de
1'expression de CD18 dans les monocytes, les polynucleaires et les
lymphocytes du bras sous garrot, compare au bras libre controle.
On a egalement retrouve une augmentation de 1'expression de
CD11b, mais pas de CD11a ou de CD11c, dans les polynucleaires
et les monocytes. Dans le meme temps, on a detecte une
reduction significative du pourcentage des polynucleaires dans les
zones ischemiques. Apres 15 minutes de reperfusion, les differ-
ences dans 1'expression de ces molecules d'adhesion n'etaient plus
significatives. L'expression des genes qui codent les cytokines
proinflammatoires IL-1-a, IL-1/3, IL-6 and TNF-a a ete egale-
ment etudiee par une reaction en chaine de polymerase inversee
dans les cellules mononucleees du sang peripherique (PBMC)
obtenues a partir de ces memes echantillons chez trois patients.
L'expression des genes IL-113 ou IL-6 n'a jamais ete observee.
L'expression des genes IL-la et TNF-a, detectec chez deux
patients, n'etait pas en rapport avec l'ischemie. Apres 15 minutes
de reperfusion, l'expression d'un ou des deux genes pouvaient etre
detectee dans les echantillons provenant du bras ischemie mais
pas dans le bras controle. Ces donnees confirment que la surex-
pression des molecules d'adhesion et la sequestration des leuco-
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cytes ont lieu apres des temps d'ischemie relativement courts, tels
que ceux qui sont entraines par les procedes chirurgicaux mineurs
de tous les jours.
Resumen
Se investigo la expresion de superficie de las integrinas-b2 en
leucocitos de pacientes sometidos a isquemia por aplicacion de un
torniquete para cirugia electiva de la mano. En 5 pacientes se
tomaron muestras de sangre antes de la iniciacion y al final de la
isquemia y luego de 15 minutos de reperfusion de la isquemia yen
el brazo contralateral. Se detecto expresion comparable de CD18,
CD11a, CD11b y CD11c mediante immunofluorescencia en leu-
cocitos de las muestras tomadas de cualquiera de los dos brazos
antes de la aplicacion del torniquete. En contraste, se detecto un
incremento significativo de la expresion de CD18 en monocitos,
granulocitos y linfocitos del brazo isquemico, en comparacion con
el control contralateral no isquemico, al final del periodo de
isquemia (80 B1 16 minutos). Tambien se observo una expresion
significativamente aumentada de CD11b, pero no de determi-
nantes de CD11a o CD11c, en granulocitos y monocitos. En forma
concomitante, se detecto una reduccion significativa en el porcen-
taje de granulocitos en muestras de territorios isquemicos. Luego
de 15 minutos de reperfusion, la diferencia en la expresion de
estas moleculas de adhesion dejo de ser significativa. La expresion
de los genes, que encodan la citocinas proinflamatorias IL-1EO,
IL-la, IL-6 y FNT-E0 tambien fue estudiada por medio de la
tecnica de rPCR en celulas sanguineas mononucleares perifericas
obtenidas a partir de las mismas muestras, en tres pacientes. No se
observo expresion del gen IL-la o IL-6. La expresion de los genes
de IL-lEO y FNT-E0, segnn fue detectada en dos pacientes, no se
relaciono con la induccion de isquemia. Sin embargo, en estos
pacientes la expresion de uno o de los dos genes pudo ser
observada en muestras derivadas del brazo isquemico pero no en
las del brazo control, despuaes de 15 minutos de reperfusion.
Estos datos documentan que la sobre-expresion de moleculas de
adhesion y el secuestro de leucocitos tienen lugar luego de cortos
tiempos de isquemia, tales como se aplican en el curso de
procedimientos quirurgicos menores.
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